Rebalix
Invesco · sheet of 5 September 2026
Invesco · sheet of 5 September 2026ETF sheet · official issuer and register data
Invesco S&P 500 Scored & Screened UCITS ETF EUR Hdg Acc
5ESE · IE000QF66PE6 · class EUR Hdg Acc · EUR · domicile Ireland
Equity · United States · Large cap · Sustainable / ESGEUR-hedged share classSFDR art. 8
Index tracked: S&P 500 Scored & Screened EUR Daily Hedged NTR Index
- TER
- 0.09%+ trans. 0.40%
- Fund size
- 3.2 bn EUR
- Tracking difference
- −0.06%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Synthetic (swap)
- Income
- Accumulating
Launch 5 Nov 2021 · costs from the KID as of 14 Aug 2026 · 129 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
Investment objective: The objective of the Fund is to achieve the net total return performance of the S&P 500 Scored & Screened Index (the "Index"), less fees, expenses and transaction costs. Investment approach: The Fund is a passively managed ETF. To achieve the objective the Fund will use unfunded swaps ("Swaps"). These Swaps are an agreement between the Fund and an approved counterparty to exchange one stream of cash flows against another stream but do not require the Fund to provide collateral, on the basis that the Fund has already invested in a…
Performance since series start (in euro) — base 100
5 Nov 2021 → 13 Aug 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +22.2% |
| 3 years | +70.3% |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +60.7% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 13.17% | 15.00% | — |
| Max drawdown | −9.97% | −19.43% | — |
| Sharpe | 1.35 | 1.02 | — |
| Sortino | 2.01 | 1.49 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · 5ESE · IE000QF66PE61
Rebalix5ESE · IE000QF66PE6 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +15.72% | +15.85% | −0.13% |
| 2024 | +21.36% | +21.44% | −0.08% |
| 2023 | +24.11% | +24.09% | +0.02% |
| 2022 | −20.25% | −20.33% | +0.08% |
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 31 Aug 2026 · 129 securities · top-10 weight = 28.4%
| Top holdings | Weight |
|---|---|
| 3.5% | |
| 3.4% | |
| 3.4% | |
| 3.3% | |
| 2.9% | |
| 2.7% | |
| 2.5% | |
| 2.3% | |
| 2.3% | |
| 2.0% |
Listing venues
ESMA register (FIRDS) and official exchange lists
5ESE · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 16 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE000QF66PE6
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE000QF66PE6
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · 5ESE · IE000QF66PE62